Impact of TP53 Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell Therapy
Insightful study that highlights how TP53 continues to be an adverse prognostic factor in DLBCL even with CAR-T therapies.
Insightful study that highlights how TP53 continues to be an adverse prognostic factor in DLBCL even with CAR-T therapies.
Images in Clinical Medicine from The New England Journal of Medicine — Clonorchis sinensis Liver Flukes
Welcome to RCNonline. Here you can watch videos from the world’s biggest nursing union.
At the 2024 UCSF-UCLA PSMA Conference, Matthias Eiber advocates for standardized reporting in PSMA PET imaging, underscoring its significance in improving clinical and research communication,…
CAR T-cell therapy is a form of immunotherapy that uses specially modified T cells — part of the body’s defense system against disease — to…
Disputes between hospitals and Medicare Advantage plans are leading to entire hospital systems suddenly leaving insurance networks. Patients are left stuck in the middle, choosing…
Fibrotic interstitial lung disease (fILD) is characterized by fibrosis of the lung tissue that often progresses over time.1 Exertional desaturation is a common feature of…
Explore this initiative designed to provide resources and community for those affected by head and neck cancer.
Autoimmune diseases have been linked to an increased risk of pregnancy-related complications. A family history of autoimmune diseases may be related t…
Digital tools can enhance maternal health and empowerment. But to be equitable, they need to be tailored to the unique experiences and needs of individuals.
How much do you know about the most recent developments in IgA nephropathy? Test your knowledge with this quick quiz.